| Identification | Back Directory | [Name]
19-Hydroxybufalin | [CAS]
39844-86-5 | [Synonyms]
19-Hydroxybufalin
Bufa-20,22-dienolide, 3,14,19-trihydroxy-, (3β,5β)- | [Molecular Formula]
C24H34O5 | [MDL Number]
MFCD30834602 | [MOL File]
39844-86-5.mol | [Molecular Weight]
402.52 |
| Chemical Properties | Back Directory | [Boiling point ]
601.7±55.0 °C(Predicted) | [density ]
1.283±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
14.92±0.70(Predicted) | [color ]
White to off-white | [InChIKey]
AXTYMYOHGWVSQN-UIJVFFKONA-N | [SMILES]
C([C@]12CC[C@H](O)C[C@@]1([H])CC[C@@]1([H])[C@]3(CC[C@H](C4=COC(=O)C=C4)[C@@]3(C)CC[C@]21[H])O)O |&1:1,4,7,11,13,16,24,28,r| |
| Hazard Information | Back Directory | [Uses]
19-Hydroxybufalin is a bufadienolide, inhibits epithelial-mesenchymal transition and attenuates the migration and invasion of PC3 cells[1]. | [References]
[1] Chen L, et al. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Pharmacol Res. 2017 Sep;123:130-142. DOI:10.1016/j.phrs.2017.07.009 |
|
| Company Name: |
cjbscvictory Gold
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|